Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers. [Phase 1]
A Phase 1 bioequivalence study evaluating a single dose of darifenacin 7.5 mg tablets in fed healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder [Phase 1]
Phase 1 clinical trial evaluating the effect of standardized fluid intake in female patients with Overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: A Clinical Study for Magnetic Stimulation of the Posterior Tibial Nerve in Overactive Bladder [NA]
This update notes the completion of a clinical study evaluating magnetic stimulation of the posterior tibial nerve for overactive bladder.
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life [Phase 4]
A Phase 4 clinical trial evaluating solifenacin (VESIcare) for symptom bother and health-related quality of life in adults with overactive b…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms [Phase 4]
A Phase 4 study evaluated the effectiveness of Urgent PC versus a sham procedure for treating overactive bladder symptoms, with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-09Clinical Trial Update: Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder. [Phase 2]
Pfizer conducted a Phase 2 dose-finding trial comparing fesoterodine to placebo for efficacy, tolerability and safety in overactive bladder;…
-
CLINICAL_TRIALS trial_result · 2010-08-26Clinical Trial Update: Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients [Phase 4]
Phase 4 clinical trial update examining the efficacy and safety of a selective serotonin reuptake inhibitor in patients with overactive blad…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder. [Phase 3]
Pfizer's long-term Phase 3 trial assessing the safety, tolerability, and efficacy of fesoterodine for overactive bladder has completed with …
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder [Phase 3]
A Phase 3 trial comparing behavioral modification plus Vesicare (solifenacin) versus Vesicare alone for urge incontinence in adults with ove…
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder [Phase 3]
This update reports the completion of a Phase 3 confirmatory trial evaluating KUC-7483 for overactive bladder.
-
CLINICAL_TRIALS trial_result · 2010-07-15Clinical Trial Update: Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder
A completed trial evaluating the combination of an anticholinergic medication with sacral neuromodulation for refractory overactive bladder.
-
CLINICAL_TRIALS trial_result · 2010-06-24Clinical Trial Update: Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females
A completed clinical trial evaluated intravesical injections of Botox for therapy-refractory overactive bladder in women.
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: Screening Method in Sacral Neuromodulation
This trial update describes the screening method used in a sacral neuromodulation study for overactive bladder and urinary retention, with t…
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo [Phase 3]
Phase 3 trial results compare an investigational drug against placebo for overactive bladder; results have been posted from the completed st…
-
CLINICAL_TRIALS trial_result · 2010-04-30Clinical Trial Update: Post Marketing Surveillance Study on Emselex After Launch in Germany
A completed post-marketing surveillance study of Emselex (mirabegron) conducted in Germany to monitor safety after its launch for overactive…
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
A completed clinical trial update reports changes in inflammatory and contractile protein expression in patients with Painful Bladder Syndro…
-
CLINICAL_TRIALS trial_result · 2010-02-11Clinical Trial Update: A Research Study for Patients With Overactive Bladder [Phase 2]
Phase 2 clinical trial sponsored by Allergan for overactive bladder and urinary incontinence has completed enrollment, with results posted o…
-
CLINICAL_TRIALS trial_result · 2010-01-11Clinical Trial Update: Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) [Phase 4]
Phase 4 clinical trial comparing solifenacin with oxybutynin for overactive bladder; the study is completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function [Phase 2]
A Phase 2 study tested whether 10 mg vardenafil taken twice daily for six weeks affects bladder function in participants with overactive bla…
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition [Phase 4]
Phase 4 clinical trial evaluating transdermal oxybutynin for overactive bladder with a neurological condition has completed and results were…
-
CLINICAL_TRIALS trial_result · 2009-12-21Clinical Trial Update: Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder [Phase 2]
Phase 2 study evaluating tolterodine, pregabalin, and a tolterodine-pregabalin combination for treating overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-28Clinical Trial Update: Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity
This completed clinical trial from Università degli Studi dell'Insubria examined ultrasonographic bladder wall thickness across different fo…
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: 516-BOTOX Urinary Incontinence Detrusor
This clinical trial update reports the completion of a study evaluating BOTOX (onabotulinumtoxinA) for urinary incontinence associated with …
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: Fesoterodine Flexible Dose Study [Phase 3]
Phase 3 study of fesoterodine with flexible dosing in adults with overactive bladder completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: A Phase II Study of KUC-7483 in Patients With Overactive Bladder [Phase 2]
Phase II study of KUC-7483 in overactive bladder has completed.